Skip to content
etfnews.live

Company

Replimune Group

United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Replimune Group?

Held by 42 covered funds. Sorted by Replimune Group’s share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
BBCVirtus LifeSci Biotech Clinical Trials0.8%
MEDXHorizon Kinetics Medical0.7%
XBIState Street(R) SPDR(R) S&P(R) Biotech0.3%
SMIZZacks Small/Mid Cap0.2%
IWCiShares Micro-Cap0.2%
IBBiShares Biotechnology0.1%
PWSPacer WealthShield0.1%
IBBQInvesco Nasdaq Biotechnology0.1%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.1%
IWNiShares Russell 2000 Value0.1%
VTWVVanguard Russell 2000 Value Index Fund0.0%
GSSCGoldman Sachs ActiveBeta(R) U.S. Small Cap Equity0.0%
RSSLGlobal X Russell 20000.0%
IWMiShares Russell 20000.0%
NSIDXSmall Cap Index Fund0.0%
RESMColumbia Research Enhanced Small Cap0.0%
SCHASchwab U.S. Small-Cap0.0%
VTWOVanguard Russell 2000 Index Fund0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
ITWOProShares Russell 2000 High Income0.0%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
DFASDimensional U.S. Small Cap0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
VXFVanguard Extended Market Index Fund0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
VHTVanguard Health Care Index Fund0.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
DFACDimensional U.S. Core Equity 20.0%
SCHBSchwab U.S. Broad Market0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
IWViShares Russell 30000.0%
DCORDimensional US Core Equity 10.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
VTIVanguard Total Stock Market Index Fund0.0%
DFQTXU.S. Core Equity 2 Portfolio0.0%
SSBIXState Street Balanced Index Fund0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTHRVanguard Russell 3000 Index Fund0.0%
TILTFlexShares Morningstar US Market Factor Tilt Index Fund0.0%
AVSCAvantis U.S. Small Cap Equity0.0%
DFUSDimensional U.S. Equity Market0.0%
DFAUDimensional US Core Equity Market0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Replimune Group news

No recent stories about Replimune Group.